Literature DB >> 15501761

RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection.

Tian Xue1, Evangelos Stavropoulos, Min Yang, Silvia Ragno, Martin Vordermeier, Mark Chambers, Glyn Hewinson, Douglas B Lowrie, M Joseph Colston, Ricardo E Tascon.   

Abstract

We have previously demonstrated that vaccination of mice with plasmid DNA vectors expressing immunodominant mycobacterial genes induced cellular immune responses and significant protection against challenge with Mycobacterium tuberculosis. We demonstrate here, using in vitro-synthesized RNA, that vaccination with DNA or RNA constructs expressing the M. tuberculosis MPT83 antigen are capable of inducing specific humoral and T-cell immune responses and confer modest but significant protection against M. tuberculosis challenge in mice. This is the first report of protective immunity conferred against intracellular bacteria by an RNA vaccine. This novel approach avoids some of the drawbacks of DNA vaccines and illustrates the potential for developing new antimycobacterial immunization strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501761      PMCID: PMC523008          DOI: 10.1128/IAI.72.11.6324-6329.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  The prime-boost strategy: exciting prospects for improved vaccination.

Authors:  I A Ramshaw; A J Ramsay
Journal:  Immunol Today       Date:  2000-04

Review 2.  On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Authors:  Kris Huygen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 3.  The TB epidemic from 1992 to 2002.

Authors:  Mario C Raviglione
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

4.  Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.

Authors:  D Boczkowski; S K Nair; J H Nam; H K Lyerly; E Gilboa
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

5.  The JAM test. A simple assay for DNA fragmentation and cell death.

Authors:  P Matzinger
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

6.  Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

Authors:  F Martinon; S Krishnan; G Lenzen; R Magné; E Gomard; J G Guillet; J P Lévy; P Meulien
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

7.  A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

Authors:  Margot A Skinner; Bryce M Buddle; D Neil Wedlock; Denise Keen; Geoffrey W de Lisle; Ricardo E Tascon; Jose Candido Ferraz; Douglas B Lowrie; Paul J Cockle; H Martin Vordermeier; R Glyn Hewinson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 8.  Technical and regulatory hurdles for DNA vaccines.

Authors:  John Donnelly; Karin Berry; Jeffrey B Ulmer
Journal:  Int J Parasitol       Date:  2003-05       Impact factor: 3.981

9.  Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis.

Authors:  P G Pal; M A Horwitz
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Sindbis virus: an efficient, broad host range vector for gene expression in animal cells.

Authors:  C Xiong; R Levis; P Shen; S Schlesinger; C M Rice; H V Huang
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

View more
  20 in total

1.  Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.

Authors:  Deyan Luo; Bing Ni; Peng Li; Wei Shi; Songle Zhang; Yue Han; Liwei Mao; Yangdong He; Yuzhang Wu; Xiliang Wang
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Comparative evaluation of MPT83 (Rv2873) for T helper-1 cell reactivity and identification of HLA-promiscuous peptides in Mycobacterium bovis BCG-vaccinated healthy subjects.

Authors:  Abu S Mustafa
Journal:  Clin Vaccine Immunol       Date:  2011-08-18

Review 3.  B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

4.  A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.

Authors:  Jose C Ferraz; Evangelos Stavropoulos; Min Yang; Steve Coade; Clara Espitia; Douglas B Lowrie; M Joseph Colston; Ricardo E Tascon
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 5.  Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Authors:  Jacqueline M Achkar; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

Review 6.  The protective role of antibody responses during Mycobacterium tuberculosis infection.

Authors:  F Abebe; G Bjune
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 7.  Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

Authors:  Jacqueline M Achkar; John Chan; Arturo Casadevall
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

8.  Where are the RNA vaccines for TB?

Authors:  Xiao-Yong Fan; Douglas Bruce Lowrie
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

Review 9.  Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?

Authors:  Hazel M Dockrell; Helen McShane
Journal:  EBioMedicine       Date:  2022-04-12       Impact factor: 11.205

10.  The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice.

Authors:  Fan F Kao; Sultana Mahmuda; Rachel Pinto; James A Triccas; Nicholas P West; Warwick J Britton
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.